ProPhase Labs, Inc.
PRPH
$0.10
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.35M | 5.06M | 5.59M | 5.85M | 6.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.35M | 5.06M | 5.59M | 5.85M | 6.77M |
| Cost of Revenue | 2.96M | 4.07M | 4.26M | 5.41M | 6.92M |
| Gross Profit | 1.38M | 987.00K | 1.33M | 436.00K | -150.00K |
| SG&A Expenses | 19.32M | 30.43M | 32.37M | 34.68M | 37.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.39M | 34.67M | 36.92M | 40.51M | 45.40M |
| Operating Income | -18.05M | -29.61M | -31.33M | -34.66M | -38.63M |
| Income Before Tax | -23.39M | -34.38M | -34.86M | -38.92M | -42.33M |
| Income Tax Expenses | 0.00 | 15.18M | 12.83M | 9.76M | 7.20M |
| Earnings from Continuing Operations | -23.39 | -49.56 | -47.69 | -48.68 | -49.53 |
| Earnings from Discontinued Operations | 8.64M | 7.86M | 6.24M | 5.55M | -3.84M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.74M | -41.70M | -41.45M | -43.13M | -53.36M |
| EBIT | -18.05M | -29.61M | -31.33M | -34.66M | -38.63M |
| EBITDA | -13.22M | -24.22M | -25.45M | -28.60M | -32.44M |
| EPS Basic | -1.93 | -15.92 | -17.73 | -19.91 | -24.51 |
| Normalized Basic EPS | -2.49 | -7.10 | -8.46 | -10.63 | -12.68 |
| EPS Diluted | -1.96 | -15.98 | -17.78 | -19.95 | -24.55 |
| Normalized Diluted EPS | -2.49 | -7.10 | -8.46 | -10.63 | -12.68 |
| Average Basic Shares Outstanding | 33.95M | 14.23M | 11.98M | 9.72M | 8.00M |
| Average Diluted Shares Outstanding | 33.95M | 14.23M | 11.98M | 9.72M | 8.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |